Table 3. Hazard ratio (95% confidence intervals) for a 1 standard deviation (6 cm) increase in height in relation to selected cancer outcomes – stratified by region and gender.

	Sex	No. of deaths*	Overall (N=506, 648)	Australasia (N=98267)	Asia (N=408,381)	P-value interaction by region
Pancreas	M F	194 100	1.08 (0.94, 1.24) 0.99 (0.82, 1.21)	1.18 (0.98, 1.43) 0.97 (0.76, 1.24)	0.97 (0.80, 1.18) 1.04 (0.76, 1.43)	0.16 0.72
Leukaemia	M F	130 59	1.03 (0.87, 1.21) 1.01 (0.79, 1.31)	0.97 (0.79, 1.18) 0.99 (0.75, 1.32)	1.16 (0.87, 1.54) 1.09 (0.64, 1.86)	0.30 0.75
Bladder	M F	97 22	1.31 (1.09, 1.58) 1.43 (0.97, 2.13)	1.35 (1.07, 1.71) 1.59 (1.02, 2.50)	1.25 (0.93, 1.68) 1.06 (0.50, 2.26)	0.68 0.30
Brain	M F	141 57	1.06 (0.90, 1.25) 0.96 (0.74, 1.25)	1.03 (0.85, 1.26) 0.94 (0.69, 1.28)	1.12 (0.86, 1.46) 1.02 (0.64, 1.65)	0.62 0.75
Kidney	M F	67 23	1.04 (0.83, 1.31) 1.21 (0.81, 1.83)	1.07 (0.82, 1.39) 1.02 (0.65, 1.59)	0.99 (0.65, 1.50) 2.53 (1.11, 5.75)	0.75 0.053
Ovary/uterus	M F	*** 195	1.08 (0.94, 1.25)	1.10 (0.91, 1.33)	1.06 (0.85, 1.31)	0.78
Melonoma	M F	63 25	1.44 (1.15, 1.79) 1.04 (0.71, 1.52)	1.46 (1.16, 1.83) 1.04 (0.71, 1.52)	1.10 (0.42, 2.87)**	0.57
Upper Aero digestive Tract	M F	329 79	0.93 (0.84, 1.04) 1.16 (0.92, 1.45)	1.01 (0.85, 1.20) 1.04 (0.70, 1.55)	0.89 (0.78, 1.02) 1.21 (0.93, 1.57)	0.26 0.53
Other	M F	546 228	1.02 (0.94, 1.11) 1.11 (0.96, 1.27)	1.12 (0.97, 1.30) 1.25 (1.00, 1.57)	0.98 (0.88, 1.08) 1.03 (0.87, 1.23)	0.13 0.18

All hazard ratios are age, study, and year of birth adjusted

^*number of events overall

^**too few events to run analyses

^***not applicable